Anbio Biotechnology

Develops and supplies in vitro diagnostic solutions for human and veterinary markets.

NNNN | NDAQ

Overview

Corporate Details

ISIN(s):: KYG0367B1059
LEI:
Country:: United States of America
Address:: FRIEDRICH-EBERT-ANLAGE 49, 60308 FRANKFURT AM MAIN
Website:: https://anbiobiotechnology.com/
Sector:: Manufacturing
Industry:: Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Anbio Biotechnology is a global medical technology company founded in 2021 that specializes in in vitro diagnostics (IVD). The company develops, manufactures, and supplies a diverse portfolio of diagnostic products for over-the-counter (OTC), point-of-care (POCT), and laboratory use, serving both human and veterinary markets. Its solutions are designed to detect a wide range of biomarkers across critical medical fields such as infectious diseases, cancer, cardiovascular diseases, and diabetes. Anbio utilizes five core technology platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR), and Loop-mediated Isothermal Amplification (LAMP). The company's mission is to advance personalized and decentralized diagnostics to improve healthcare outcomes worldwide.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Anbio Biotechnology filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Anbio Biotechnology

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Anbio Biotechnology via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Cellid Co., Ltd. Biotech firm developing proprietary vaccine platforms for cancer and infectious diseases.	South Korea	299660
Cellromax Science Co., Ltd. Develops health foods, derma-cosmetics, and OTC drugs for pharmacies and online channels.	South Korea	471820
CellSeed Inc. Develops cell sheet products, culture equipment, and offers contract manufacturing services.	Japan	7776
CellSource Co.,Ltd. Processes patient-derived stem cells and PRP for regenerative therapies at medical facilities.	Japan	4880
Celltrion, Inc. A biopharma pioneer developing biosimilars and novel drugs for immunology and oncology.	South Korea	068270
Celon Pharma S.A. Researches, develops, and markets innovative drugs for oncology and neurology.	Poland	CLN
CEL SCI CORP Develops immunotherapies for cancer, autoimmune, and infectious diseases.	United States of America	CVM
Celularity Inc Develops off-the-shelf cell therapies from placentas for cancer and aging-related diseases.	United States of America	CELU
Centessa Pharmaceuticals plc Develops medicines for sleep-wake disorders, hemophilia, and other unmet medical needs.	United States of America	CNTA
CERO THERAPEUTICS HOLDINGS, INC. Develops engineered T-cell immunotherapies for cancer using its proprietary CER platform.	United States of America	CERO